# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
139, Journal, 0, 19, "Srp Arh Celok Lek .", "", "<http://ctro/data#Publication_48066> <http://ctro/data#hasJournal> \"Srp Arh Celok Lek .\"."
0, PublicationYear, 20, 24, "2007", "", "<http://ctro/data#Publication_48066> <http://ctro/data#hasPublicationYear> \"2007\"."
140, Title, 64, 187, "[ The effect of metformin on fasting and postprandial insulin secretion in obese patients with diabetes mellitus type 2 ] .", "", "<http://ctro/data#Publication_48066> <http://ctro/data#hasTitle> \"[ The effect of metformin on fasting and postprandial insulin secretion in obese patients with diabetes mellitus type 2 ] .\"."
1, Metformin, 80, 89, "metformin", "", 
49950, EndPointDescription, 93, 135, "fasting and postprandial insulin secretion", "", 
49950, EndPointDescription, 105, 135, "postprandial insulin secretion", "", 
2, Insulin, 118, 125, "insulin", "", 
4, Precondition, 139, 183, "obese patients with diabetes mellitus type 2", "", 
3, Type2Diabetes, 159, 183, "diabetes mellitus type 2", "", 
9, Country, 201, 208, "Serbian", "", "<http://ctro/data#Country_48100> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Country>. <http://ctro/data#Population_48097> <http://ctro/data#hasCountry> <http://ctro/data#Country_48100>."
5, Author, 211, 221, "Vukovi ć M", "", "<http://ctro/data#Publication_48066> <http://ctro/data#hasAuthor> \"Vukovi ć M\"."
6, Author, 224, 235, "Lapcevi ć M", "", "<http://ctro/data#Publication_48066> <http://ctro/data#hasAuthor> \"Lapcevi ć M\"."
7, Author, 238, 248, "Kalezi ć N", "", "<http://ctro/data#Publication_48066> <http://ctro/data#hasAuthor> \"Kalezi ć N\"."
8, Author, 251, 266, "Gvozdenovi ć BS", "", "<http://ctro/data#Publication_48066> <http://ctro/data#hasAuthor> \"Gvozdenovi ć BS\"."
10, Metformin, 333, 342, "metformin", "", 
11, Insulin, 379, 386, "insulin", "", 
142, ObjectiveDescription, 499, 612, "The purpose of the study was to establish the effect of metformin on fasting and postprandial insulin secretion .", "", "<http://ctro/data#ClinicalTrial_48076> <http://ctro/data#hasObjectiveDescription> \"The purpose of the study was to establish the effect of metformin on fasting and postprandial insulin secretion .\"."
12, Metformin, 555, 564, "metformin", "", 
49954, EndPointDescription, 568, 610, "fasting and postprandial insulin secretion", "", 
49953, EndPointDescription, 580, 610, "postprandial insulin secretion", "", 
146, Insulin, 593, 600, "insulin", "", 
13, DoubleBlind, 648, 660, "double blind", "", "<http://ctro/data#ClinicalTrial_48076> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
14, CTDesign, 663, 673, "controlled", "", "<http://ctro/data#CTDesign_48092> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTDesign>. <http://ctro/data#ClinicalTrial_48076> <http://ctro/data#hasCTDesign> <http://ctro/data#CTDesign_48092>."
15, CTDesign, 676, 687, "comparative", "", "<http://ctro/data#CTDesign_48093> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#CTDesign>. <http://ctro/data#ClinicalTrial_48076> <http://ctro/data#hasCTDesign> <http://ctro/data#CTDesign_48093>."
16, Randomized, 690, 700, "randomized", "", "<http://ctro/data#ClinicalTrial_48076> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
17, Multicenter, 703, 715, "multicentric", "", "<http://ctro/data#ClinicalTrial_48076> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
19, NumberPatientsArm, 786, 788, "43", "", 
20, Metformin, 816, 825, "metformin", "", "<http://ctro/data#Medication_48147> <http://ctro/data#hasDrug> <http://ctro/data#Metformin>."
21, NumberPatientsArm, 853, 855, "46", "", "<http://ctro/data#Arm_48126> <http://ctro/data#hasNumberPatientsArm> \"46\"."
22, Placebo, 876, 883, "placebo", "", "<http://ctro/data#Medication_48154> <http://ctro/data#hasDrug> <http://ctro/data#Placebo>."
96, Precondition, 922, 1053, "newly diagnosed with diabetes mellitus ( DM ) type 2 , glycaemia < 12 mmol / l , and had the Body Mass Index ( BMI ) > 30 kg / m2 .", "", "<http://ctro/data#Population_48097> <http://ctro/data#hasPrecondition> \"newly diagnosed with diabetes mellitus ( DM ) type 2 , glycaemia < 12 mmol / l , and had the Body Mass Index ( BMI ) > 30 kg / m2 .\"."
23, Type2Diabetes, 943, 974, "diabetes mellitus ( DM ) type 2", "", "<http://ctro/data#ClinicalTrial_48076> <http://ctro/data#analysesHealthCondition> <http://ctro/data#Type2Diabetes>."
24, Millimoles_per_litre, 992, 1000, "mmol / l", "", 
25, BMI, 1015, 1030, "Body Mass Index", "", 
26, BMI, 1033, 1036, "BMI", "", 
27, Kg_per_squareMeter, 1044, 1051, "kg / m2", "", 
148, FastingBloodGlucose, 1103, 1137, "fasting and postprandial glycaemia", "", 
149, PostprandialBloodGlucose, 1115, 1137, "postprandial glycaemia", "", 
28, HbA1c, 1140, 1164, "glycosylated haemoglobin", "", 
29, HbA1c, 1167, 1172, "HbA1c", "", 
49960, EndPointDescription, 1183, 1220, "fasting and postprandial insulinaemia", "", 
49961, EndPointDescription, 1195, 1220, "postprandial insulinaemia", "", 
30, EndPointDescription, 1223, 1235, "blood lipids", "", 
34, EndPointDescription, 1244, 1255, "cholesterol", "", 
35, EndPointDescription, 1264, 1277, "triglycerides", "", 
36, EndPointDescription, 1280, 1295, "HDL cholesterol", "", 
37, EndPointDescription, 1302, 1317, "LDL cholesterol", "", 
32, EndPointDescription, 1326, 1352, "gamma glutaryl transferase", "", 
33, EndPointDescription, 1355, 1358, "GGT", "", 
38, BMI, 1369, 1372, "BMI", "", 
39, Duration, 1402, 1409, "42 days", "", 
49962, EndPointDescription, 1425, 1462, "fasting and postprandial insulinaemia", "", 
49963, EndPointDescription, 1437, 1462, "postprandial insulinaemia", "", 
49964, EndPointDescription, 1560, 1597, "fasting and postprandial insulinaemia", "", 
49965, EndPointDescription, 1572, 1597, "postprandial insulinaemia", "", 
42, MeasurementDevice, 1613, 1626, "ANOVA two way", "", "<http://ctro/data#MeasurementDevice_48109> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice>. <http://ctro/data#Endpoint_48105> <http://ctro/data#hasMeasurementDevice> <http://ctro/data#MeasurementDevice_48109>. <http://ctro/data#MeasurementDevice_48115> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice>. <http://ctro/data#Endpoint_48111> <http://ctro/data#hasMeasurementDevice> <http://ctro/data#MeasurementDevice_48115>."
43, MeasurementDevice, 1631, 1644, "ANCOVA method", "", "<http://ctro/data#MeasurementDevice_48110> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice>. <http://ctro/data#Endpoint_48105> <http://ctro/data#hasMeasurementDevice> <http://ctro/data#MeasurementDevice_48110>. <http://ctro/data#MeasurementDevice_48116> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#MeasurementDevice>. <http://ctro/data#Endpoint_48111> <http://ctro/data#hasMeasurementDevice> <http://ctro/data#MeasurementDevice_48116>."
44, Metformin, 1675, 1684, "metformin", "", 
45, Placebo, 1722, 1729, "placebo", "", 
114, EndPointDescription, 1764, 1784, "fasting insulinaemia", "", "<http://ctro/data#EndPointDescription_48106> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_48105> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_48106>."
46, Duration, 1798, 1807, "six weeks", "", "<http://ctro/data#ClinicalTrial_48076> <http://ctro/data#hasCTduration> \"six weeks\"."
47, Type2Diabetes, 1842, 1851, "DM type 2", "", 
49, ResultMeasuredValue, 1854, 1862, "24 . 392", "", "<http://ctro/data#Outcome_48161> <http://ctro/data#hasResultMeasuredValue> \"24 . 392\"."
117, MilliUnits_per_litre, 1863, 1869, "mU / l", "", "<http://ctro/data#Endpoint_48105> <http://ctro/data#hasBaselineUnit> <http://ctro/data#MilliUnits_per_litre>."
52, ResultMeasuredValue, 1875, 1883, "25 . 667", "", "<http://ctro/data#Outcome_48188> <http://ctro/data#hasResultMeasuredValue> \"25 . 667\"."
118, MilliUnits_per_litre, 1884, 1890, "mU / l", "", 
53, BMI, 1917, 1920, "BMI", "", "<http://ctro/data#Outcome_48188> <http://ctro/data#hasResultMeasuredValue> \"25 . 667\"."
49959, EndPointDescription, 1958, 1978, "fasting insulinaemia", "", 
54, PvalueDiff, 1995, 2006, "p < 0 . 001", "", "<http://ctro/data#DiffBetweenGroups_48215> <http://ctro/data#hasPvalueDiff> \"p < 0 . 001\"."
55, BMI, 2065, 2068, "BMI", "", 
56, EndPointDescription, 2073, 2076, "GGT", "", 
49956, EndPointDescription, 2123, 2148, "postprandial insulinaemia", "", "<http://ctro/data#EndPointDescription_48112> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#EndPointDescription>. <http://ctro/data#Endpoint_48111> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#EndPointDescription_48112>."
57, BMI, 2228, 2231, "BMI", "", 
49958, EndPointDescription, 2268, 2293, "postprandial insulinaemia", "", 
58, PvalueDiff, 2342, 2352, "p < 0 . 01", "", "<http://ctro/data#DiffBetweenGroups_48278> <http://ctro/data#hasPvalueDiff> \"p < 0 . 01\"."
121, Mean, 2366, 2370, "mean", "", "<http://ctro/data#Mean_48113> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_48111> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_48113>."
122, EndPointDescription, 2382, 2407, "postprandial insulinaemia", "", "<http://ctro/data#Mean_48113> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_48111> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_48113>."
59, Placebo, 2429, 2436, "placebo", "", 
60, Metformin, 2473, 2482, "metformin", "", 
63, ResultMeasuredValue, 2491, 2499, "44 . 807", "", "<http://ctro/data#Outcome_48251> <http://ctro/data#hasResultMeasuredValue> \"44 . 807\"."
128, MilliUnits_per_litre, 2500, 2506, "mU / l", "", "<http://ctro/data#Endpoint_48111> <http://ctro/data#hasBaselineUnit> <http://ctro/data#MilliUnits_per_litre>."
64, ResultMeasuredValue, 2512, 2520, "47 . 114", "", "<http://ctro/data#Outcome_48224> <http://ctro/data#hasResultMeasuredValue> \"47 . 114\"."
127, MilliUnits_per_litre, 2521, 2527, "mU / l", "", 
137, ConclusionComment, 2545, 2693, "It can be concluded that , as compared to place - bo , metformin is more efficient in reducing insulin resistance in obese patients with DM type 2 .", "", "<http://ctro/data#ClinicalTrial_48076> <http://ctro/data#hasConclusionComment> \"It can be concluded that , as compared to place - bo , metformin is more efficient in reducing insulin resistance in obese patients with DM type 2 .\"."
65, Placebo, 2587, 2597, "place - bo", "", 
66, Metformin, 2600, 2609, "metformin", "", 
67, Insulin, 2640, 2647, "insulin", "", 
68, Type2Diabetes, 2682, 2691, "DM type 2", "", 
138, ConclusionComment, 2694, 2873, "In addition , as compared to placebo , metformin maintains more efficient productive insulin secretion , indicating that metformin protects the pancreas from beta cell depletion .", "", "<http://ctro/data#ClinicalTrial_48076> <http://ctro/data#hasConclusionComment> \"In addition , as compared to placebo , metformin maintains more efficient productive insulin secretion , indicating that metformin protects the pancreas from beta cell depletion .\"."
70, Placebo, 2723, 2730, "placebo", "", 
71, Metformin, 2733, 2742, "metformin", "", 
49957, EndPointDescription, 2779, 2796, "insulin secretion", "", 
72, Insulin, 2779, 2786, "insulin", "", 
73, Metformin, 2815, 2824, "metformin", "", 
74, PMID, 2881, 2889, "17929538", "", "<http://ctro/data#Publication_48066> <http://ctro/data#hasPMID> \"17929538\"."
